The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations
- PMID: 27322166
- DOI: 10.1097/FTD.0000000000000316
The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations
Abstract
Background: Carbapenem antibiotics (CBPMs) may significantly reduce the serum concentration of valproic acid (VPA), but the extent of this effect among various CBPMs is unknown. This study compared the extent and onset of the interactions among ertapenem, imipenem/cilastatin, and meropenem.
Methods: A 5-year retrospective study was performed. Hospitalized patients over 18 years old who received VPA and a CBPM concurrently were enrolled via the pharmacy computer system. Patients who lacked VPA serum concentration measurements before or during CBPMs' use, had concurrent medication(s) that might interfere with VPA metabolism, or had a history of liver cirrhosis were excluded. Total VPA serum concentrations before and during CBPMs' use and after its discontinuation were recorded, and differences among various CBPMs were analyzed.
Results: Fifty-two patients were included in this analysis. Irrespective of the route of administration, VPA serum concentrations were subtherapeutic in 90% of the subjects during CBPMs' use. There was a significant decrease (P < 0.001) in VPA serum concentrations during the use of CBPMs: 72% ± 17%, 42% ± 22%, and 67% ± 19% in the ertapenem (N = 9), imipenem/cilastatin (N = 17), and meropenem (N = 26) groups, respectively. The effect of ertapenem and meropenem on VPA was significantly more expressed than that of imipenem/cilastatin (P < 0.005). The onset of this drug interaction occurred within 24 hours of CBPMs' administration, and VPA serum concentrations returned to 90% of baseline within 7 days of CBPMs' discontinuation along with a 20% increase in VPA dose. Increasing VPA dose during the use of ertapenem or meropenem did not result in elevating VPA serum concentrations to therapeutic levels during the combined therapy period.
Conclusions: CBPMs reduced VPA serum concentration within 24 hours of administration by approximately 60%. Ertapenem and meropenem had a greater effect on VPA serum concentration than imipenem/cilastatin. Because of the dramatic reduction of VPA serum concentration during CBPMs' use, concomitant use of VPA and CBPMs should be avoided.
Similar articles
-
Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases.Ther Drug Monit. 2012 Oct;34(5):599-603. doi: 10.1097/FTD.0b013e318260f7b3. Ther Drug Monit. 2012. PMID: 22929406
-
Unusual drug reaction between valproate sodium and meropenem.Int J Clin Pharm. 2013 Jun;35(3):316-8. doi: 10.1007/s11096-013-9763-2. Epub 2013 Mar 13. Int J Clin Pharm. 2013. PMID: 23483443
-
[Seven cases of decreased serum valproic acid concentration during concomitant use of carbapenem antibiotics].Korean J Lab Med. 2007 Oct;27(5):338-43. doi: 10.3343/kjlm.2007.27.5.338. Korean J Lab Med. 2007. PMID: 18094598 Korean.
-
Valproic acid-carbapenem interaction: report of six cases and a review of the literature.Drug Metabol Drug Interact. 2009;24(2-4):153-82. doi: 10.1515/dmdi.2009.24.2-4.153. Drug Metabol Drug Interact. 2009. PMID: 20408498 Review.
-
Interaction between valproic acid and carbapenem antibiotics.Drug Metab Rev. 2007;39(4):647-57. doi: 10.1080/03602530701690341. Drug Metab Rev. 2007. PMID: 18058328 Review.
Cited by
-
Evaluating Clinical Sequelae of the Carbapenem-Valproate Interaction: A Retrospective Analysis.Open Forum Infect Dis. 2024 Mar 8;11(3):ofae130. doi: 10.1093/ofid/ofae130. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38524229 Free PMC article.
-
[Pharmacotherapy and intensive care aspects of status epilepticus: update 2020/2021].Anaesthesist. 2021 Oct;70(10):874-887. doi: 10.1007/s00101-021-01000-y. Epub 2021 Jul 1. Anaesthesist. 2021. PMID: 34212230 Free PMC article. Review. German.
-
Retrospective Analysis of Steady-State Sodium Valproate Plasma Concentrations in Chinese Patients With Bipolar Disorder: Impact of Demographic and Clinical Characteristics.Ther Drug Monit. 2024 Oct 1;46(5):658-663. doi: 10.1097/FTD.0000000000001199. Epub 2024 Apr 19. Ther Drug Monit. 2024. PMID: 38648661 Free PMC article.
-
Carbapenems and valproate: A consumptive relationship.Epilepsia Open. 2016 Dec 26;2(1):107-111. doi: 10.1002/epi4.12030. eCollection 2017 Mar. Epilepsia Open. 2016. PMID: 29750220 Free PMC article.
-
Fixed parameters in the population pharmacokinetic modeling of valproic acid might not be suitable: external validation in Chinese adults with epilepsy or after neurosurgery.Eur J Clin Pharmacol. 2024 Nov;80(11):1819-1828. doi: 10.1007/s00228-024-03746-x. Epub 2024 Aug 29. Eur J Clin Pharmacol. 2024. PMID: 39210212
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources